The FDA just rejected Allergan’s women’s health drug (AGN)

By FDA, Pharmaceutical

The FDA just rejected Allergan’s women’s health drug (AGN)

Allergan said on Tuesday that the Food and Drug Administration would not approve one of its women’s health drugs, Esmya.

The drug was being investigated to treat uterine fibroids, a condition characterized by benign tumors that grow in and around the uterus that can cause heavy bleeding and pain.

Markets Insider

https://markets.businessinsider.com/news/stocks/allergan-stock-price-after-fda-esmya-uterine-fibroids-rejection-2018-8-1027477259

Allergan Falls on FDA’s Rejection of Uterine Fibroids Drug – August 22, 2018 – Zacks.com

https://www.zacks.com/stock/news/319081/allergan-falls-on-fdas-rejection-of-uterine-fibroids-drug?cid=CS-ZC-FT-319081

More from tokioX :

  1. U.S. Government Sues Gilead over Alleged Infringement on HIV Prevention Drug
  2. Opioid Crackdown Could Lead To More Drug Company Bankruptcies
  3. FDA: Eisai ‘s “Rembima” approved as a hepatocellular cancer drug
  4. China’s drug regulator launches nationwide investigation into vaccine producers
  5. 23andMe Is Sharing Its 5 Million Clients’ Genetic Data with Drug Giant GlaxoSmithKline
  6. 💊FDA PHARMA TODAY
  7. 💊the latest FDA approval